Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Minoryx Therapeutics S.L.
Sponsor

Minoryx Therapeutics S.L.

Spain Carrer D Ernest Lluch 32 Tcm 2, 08302 Mataró, Spain

About the sponsor

Minoryx Therapeutics S.L. focuses on clinical research in adrenoleukodystrophy, with particular attention to cerebral X-linked adrenoleukodystrophy and cerebral adrenoleukodystrophy. Its studies examine neurological disease progression, brain involvement, and treatment effects in pediatric and adult populations affected by these rare disorders.

  • cerebral X-linked adrenoleukodystrophy
  • cerebral adrenoleukodystrophy
  • neurological disease progression

The research portfolio includes clinical evaluation of leukodystrophy-related outcomes, with emphasis on central nervous system disease and MRI-based assessment of cerebral involvement.

About Specializations

Minoryx Therapeutics S.L. runs clinical trials in conditions such as Adrenoleukodystrophy, Rett syndrome, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

4 clinical trials

Adrenoleukodystrophy

Not recruiting

Study of drug interactions between leriglitazone, gemfibrozil, itraconazole, and carbamazepine and food effects in healthy male volunteers for adrenoleukodystrophy treatment

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · Healthy volunteers
  • Substances:Carbamazepine
  • Sponsor:Minoryx Therapeutics S.L.

Rett syndrome

Not recruiting

Study on the Safety and Tolerability of Leriglitazone for Children with Rett Syndrome

Investigational
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Leriglitazone
  • Sponsor:Minoryx Therapeutics S.L.

Adrenoleukodystrophy

Not recruiting

Study on the Effects of Leriglitazone in Male Children with Cerebral X-Linked Adrenoleukodystrophy Before Stem Cell Transplant

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:Leriglitazone
  • Sponsor:Minoryx Therapeutics S.L.

Adrenoleukodystrophy

Not recruiting

Study on the Effects of Leriglitazone for Adult Men with Cerebral Adrenoleukodystrophy

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Leriglitazone
  • Sponsor:Minoryx Therapeutics S.L.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.